Publications To Date

    NANOSTRING PUBLICATIONS

    Filter Publications

    PAGE 75 OF 78 | DISPLAYING 1111 - 1125 OF 1170 RESULTS

    Jeselsohn R.M. et al., Digital quantification of gene expression in sequential breast cancer biopsies reveals activation of an immune response., [Epub ahead of print]., PloS One, May 31, 2013

    Galli R. et al., Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RARβ and tumor regression., [Epub ahead of print]., PNAS, May 28, 2013

    Acunzo M. et al., Cross-talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2., 110(21):8573-8., PNAS, May 21, 2013

    Pichiorri F. et al., In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation., 210(5):951-68., J Exp Med., May 06, 2013

    Marcucci G et al., Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients., [Epub ahead of print]., J. Clin. Oncol., May 06, 2013

    Seo J.H. et al., Deconvoluting complex tissues for expression quantitative trait locus-based analyses., 368(1620):20120363., Philos Trans R Soc Lond B Biol Sci., May 06, 2013

    Manoranjan B. et al., FoxG1 interacts with Bmi1 to regulate self-renewal and tumorigenicity of medulloblastoma stem cells., [Epub ahead of print]., Stem Cells, Apr 17, 2013

    Zhuang G. et al., Phosphoproteomic analysis implicates the mTORC2-FoxO1 axis in VEGF signaling and feedback activation of receptor tyrosine kinases., [Epub ahead of print]., Sci. Signal, Apr 16, 2013

    Sakuishi K. et al., TIM3+FOXP3+ regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer., 2(4): e23849., OncoImmunology, Apr 01, 2013

    Klco J.M. et al., Genomic impact of transient low-dose decitabine treatment on primary AML cells., 121, 9: 1633-1643, Blood, Feb 28, 2013

    Reipas K.M. et al., Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1)., 4(2): 329–345., Oncotarget, Feb 27, 2013

    Hudson R.S. et al., Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer., [Epub ahead of print]., Mol Cancer, Feb 14, 2013

    Morgan R.A. et al., Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy., 36(2):133-51, J of Immunother, Feb 14, 2013

    Bhola N. E. et al., TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer., [Epub ahead of print]., JCI, Feb 08, 2013

    Cascione L. et al., Integrated MicroRNA and mRNA Signatures Associated with Survival in Triple Negative Breast Cancer., [Epub ahead of print]., PLoS ONE, Feb 08, 2013